Summary of findings table ‐ Continuation vs reduction of polypharmacy
Adverse effects – leaving the study early due to adverse effects – overall tolerability – total · patients with schizophrenia
It is very uncertain whether summary of findings table ‐ Continuation changes adverse effects – leaving the study early due to adverse effects –… compared with reduction of polypharmacy (very low certainty).
1 finding from 1 review
- Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia 2022 · Cochrane Headline outcomes onlyRR 4.37 [0.77, 24.88]3 studies · 176 participantsVery low